Clinical Trial Update: ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults [Phase 4]

View source ↗

Summary

Phase 4 trial assessing VIVITROL (naltrexone extended-release) for alcohol craving in treatment-seeking adults with alcohol dependence; results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Alcohol Dependence | Phase 4 | Status: COMPLETED | Results posted: 2010-12-07